AUERBACH ALAN H 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Feb 14, 2024
Insider Transaction Report
Form 4
AUERBACH ALAN H
DirectorPresident and CEO10% Owner
Transactions
- Award
Common Stock
2024-02-12+160,796→ 7,097,743 total - Award
Stock Option (Right to Buy)
2024-02-12+222,573→ 222,573 totalExercise: $6.36Exp: 2034-02-11→ Common Stock (222,573 underlying)
Footnotes (2)
- [F1]Subject to Grantee's continued status as an Employee of the Company, the Restricted Stock Units ("RSUs") shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events.
- [F2]Subject to Optionee's continued status as an Employee of the Company, Options shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares (as defined in the Plan) subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events.